{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:29:44Z","timestamp":1791772184062,"version":"4.3.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015690","name":"Universitas Padjadjaran","doi-asserted-by":"publisher","award":["No. 3897\/UN6.3.1\/PT.00\/2025"],"award-info":[{"award-number":["No. 3897\/UN6.3.1\/PT.00\/2025"]}],"id":[{"id":"10.13039\/501100015690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s44446-026-00110-1","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:22:55Z","timestamp":1785421375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs"],"prefix":"10.1007","volume":"34","author":[{"given":"Arif","family":"Budiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila Dwi","family":"Rahmaharva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Chiara","family":"Putri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella Aurelia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Frederica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshella Dhanu","family":"Ardhita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melsa","family":"Destia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Marcelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Amaliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Subra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diah Lia","family":"Aulifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"110_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/pharmaceutics15020713","volume":"15","author":"HA Abou-Taleb","year":"2023","unstructured":"Abou-Taleb HA, Shoman ME, Makram TS, Abdel-Aleem JA, Abdelkader H (2023) Exploration of the safety and solubilization, dissolution, analgesic effects of common basic excipients on the NSAID drug ketoprofen. Pharmaceutics 15:713. https:\/\/doi.org\/10.3390\/pharmaceutics15020713","journal-title":"Pharmaceutics"},{"key":"110_CR2","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1039\/C8CE01075G","volume":"21","author":"S Allu","year":"2019","unstructured":"Allu S, Suresh K, Bolla G, Mannava MKC, Nangia A (2019) Role of hydrogen bonding in cocrystals and coamorphous solids: indapamide as a case study. CrystEngComm 21:2043\u20132048. https:\/\/doi.org\/10.1039\/C8CE01075G","journal-title":"CrystEngComm"},{"key":"110_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ijpharm.2015.08.101","volume":"495","author":"A Alhalaweh","year":"2015","unstructured":"Alhalaweh A, Alzghoul A, Mahlin D, Bergstr\u00f6m CAS (2015) Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability. Int J Pharm 495:312\u2013317. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.08.101","journal-title":"Int J Pharm"},{"key":"110_CR4","doi-asserted-by":"publisher","first-page":"106094","DOI":"10.1016\/j.mssp.2021.106094","volume":"135","author":"N Amini","year":"2021","unstructured":"Amini N, Pries J, Cheng Y, Persch C, Wuttig M, Stolpe M, Wei S (2021) Thermodynamics and kinetics of glassy and liquid phase-change materials. Mater Sci Semicond Process 135:106094. https:\/\/doi.org\/10.1016\/j.mssp.2021.106094","journal-title":"Mater Sci Semicond Process"},{"key":"110_CR5","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.4314\/tjpr.v21i7.1","volume":"21","author":"SO Arag\u00f3n-Aburto","year":"2022","unstructured":"Arag\u00f3n-Aburto SO, Mondrag\u00f3n-V\u00e1squez K, Valerio- Alfaro G, Dom\u00ednguez-Ch\u00e1vez JG (2022) Characterization, stability and solubility of co-amorphous systems of glibenclamide and L-arginine at different pH. Trop J Pharm Res 21:1355\u20131364. https:\/\/doi.org\/10.4314\/tjpr.v21i7.1","journal-title":"Trop J Pharm Res"},{"key":"110_CR6","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"S Baghel","year":"2016","unstructured":"Baghel S, Cathcart H, O\u2019Reilly NJ (2016) Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci 105:2527\u20132544. https:\/\/doi.org\/10.1016\/j.xphs.2015.10.008","journal-title":"J Pharm Sci"},{"key":"110_CR7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1021\/acs.jpcb.3c07411","volume":"128","author":"Y Bai","year":"2024","unstructured":"Bai Y, Xu H, Wang H, Fan Y, Li X, Li Y, Fan L, Zhang Y, Qi L, Li Y (2024) Highly efficient loading of procaine on water-soluble carbon dots toward long-acting anesthesia. J Phys Chem B 128:1700\u20131710. https:\/\/doi.org\/10.1021\/acs.jpcb.3c07411","journal-title":"J Phys Chem B"},{"key":"110_CR8","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/jps.22197","volume":"99","author":"JA Baird","year":"2010","unstructured":"Baird JA, Van Eerdenbrugh B, Taylor LS (2010) A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci 99:3787\u20133806. https:\/\/doi.org\/10.1002\/jps.22197","journal-title":"J Pharm Sci"},{"key":"110_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/pharmaceutics17101249","volume":"17","author":"HP Bhatta","year":"2025","unstructured":"Bhatta HP, Han H-K, Maharjan R, Jeong SH (2025) Recent techniques to improve amorphous dispersion performance with quality design, physicochemical monitoring, molecular simulation, and machine learning. Pharmaceutics 17:1249. https:\/\/doi.org\/10.3390\/pharmaceutics17101249","journal-title":"Pharmaceutics"},{"key":"110_CR10","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1021\/acs.molpharmaceut.6b00650","volume":"13","author":"LI Blaabjerg","year":"2016","unstructured":"Blaabjerg LI, Lindenberg E, L\u00f6bmann K, Grohganz H, Rades T (2016) Glass forming ability of amorphous drugs investigated by continuous cooling and isothermal transformation. Mol Pharm 13:3318\u20133325. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00650","journal-title":"Mol Pharm"},{"key":"110_CR11","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/j.xphs.2019.02.028","volume":"108","author":"LI Blaabjerg","year":"2019","unstructured":"Blaabjerg LI, Bulduk B, Lindenberg E, L\u00f6bmann K, Rades T, Grohganz H (2019) Influence of glass forming ability on the physical stability of supersaturated amorphous solid dispersions. J Pharm Sci 108:2561\u20132569. https:\/\/doi.org\/10.1016\/j.xphs.2019.02.028","journal-title":"J Pharm Sci"},{"key":"110_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ph15060730","volume":"15","author":"A Budiman","year":"2022","unstructured":"Budiman A, Aulifa DL (2022a) A comparative study of the pharmaceutical properties between amorphous drugs loaded-mesoporous silica and pure amorphous drugs prepared by solvent evaporation. Pharmaceuticals (Basel) 15:730. https:\/\/doi.org\/10.3390\/ph15060730","journal-title":"Pharmaceuticals (Basel)"},{"key":"110_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/ph15010093","volume":"15","author":"A Budiman","year":"2022","unstructured":"Budiman A, Aulifa DL (2022b) Characterization of drugs with good glass formers in loaded-mesoporous silica and its theoretical value relevance with mesopores surface and pore-filling capacity. Pharmaceuticals (Basel) 15:93. https:\/\/doi.org\/10.3390\/ph15010093","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"110_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.22159\/ijap.2019v11i4.33802","volume":"11","author":"AR Budiman","year":"2019","unstructured":"Budiman AR, Husni PA, Shafira AT (2019) The development of glibenclamide-saccharin cocrystal tablet formulations to increase the dissolution rate of the drug. Int J Appl Pharm 11(4):359\u201364. https:\/\/doi.org\/10.22159\/ijap.2019v11i4.33802","journal-title":"Int J Appl Pharm"},{"key":"110_CR15","doi-asserted-by":"publisher","first-page":"120492","DOI":"10.1016\/j.ijpharm.2021.120492","volume":"600","author":"A Budiman","year":"2021","unstructured":"Budiman A, Higashi K, Ueda K, Moribe K (2021) Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silica. Int J Pharm 600:120492. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120492","journal-title":"Int J Pharm"},{"issue":"5","key":"110_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/polym15051282","volume":"15","author":"A Budiman","year":"2023","unstructured":"Budiman A, Kalina K, Aristawidya L, Shofwan AA, Rusdin A, Aulifa DL (2023) Characterizing the impact of chitosan on the nucleation and crystal growth of ritonavir from supersaturated solutions. Polymers 15(5):1282. https:\/\/doi.org\/10.3390\/polym15051282","journal-title":"Polymers"},{"issue":"15","key":"110_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/polym17152059","volume":"17","author":"A Budiman","year":"2025","unstructured":"Budiman A, Ivana H, Huang KA, Huang SA, Nadhira MS, Rusdin A, Aulifa DL (2025) Biocompatible natural polymer-based amorphous solid dispersion system improving drug physicochemical properties, stability, and efficacy. Polymers 17(15):2059. https:\/\/doi.org\/10.3390\/polym17152059","journal-title":"Polymers"},{"key":"110_CR18","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.3390\/molecules29235610","volume":"29","author":"A Buscarini","year":"2024","unstructured":"Buscarini A, Zaworotko MJ, Matos CRMO, Grepioni F, Contini L, Capsoni D, Friuli V, Maggi L, Bruni G (2024) Pimozide and adipic acid: a new multicomponent crystalline entity for improved pharmaceutical behavior. Molecules 29:5610. https:\/\/doi.org\/10.3390\/molecules29235610","journal-title":"Molecules"},{"key":"110_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijpharm.2016.10.043","volume":"515","author":"RB Chavan","year":"2016","unstructured":"Chavan RB, Thipparaboina R, Kumar D, Shastri NR (2016) Co amorphous systems: a product development perspective. Int J Pharm 515:403\u2013415. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.043","journal-title":"Int J Pharm"},{"key":"110_CR20","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1016\/j.xphs.2019.09.013","volume":"108","author":"N Chieng","year":"2019","unstructured":"Chieng N, Teo X, Cheah MH, Choo ML, Chung J, Hew TK, Keng PS (2019) Molecular dynamics and physical stability of pharmaceutical co-amorphous systems: correlation between structural relaxation times measured by kohlrausch-williams-watts with the width of the glass transition temperature (\u0394Tg) and the onset of crystallization. J Pharm Sci 108:3848\u20133858. https:\/\/doi.org\/10.1016\/j.xphs.2019.09.013","journal-title":"J Pharm Sci"},{"key":"110_CR21","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1021\/acs.molpharmaceut.5c01901","volume":"23","author":"ML Cousineau","year":"2026","unstructured":"Cousineau ML, Deac A, Purohit HS, Zhang GGZ, Gao Y, Taylor LS (2026) Hydrogen bonding as a failure mechanism for release of ibuprofen-copovidone amorphous solid dispersions. Mol Pharm 23:2119\u20132130. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c01901","journal-title":"Mol Pharm"},{"key":"110_CR22","doi-asserted-by":"publisher","first-page":"117549","DOI":"10.1016\/j.ces.2022.117549","volume":"253","author":"Y Deng","year":"2022","unstructured":"Deng Y, Deng W, Huang W, Zheng Z, Zhang R, Liu S, Jiang Y (2022) Norfloxacin co-amorphous salt systems: effects of molecular descriptors on the formation and physical stability of co-amorphous systems. Chem Eng Sci 253:117549. https:\/\/doi.org\/10.1016\/j.ces.2022.117549","journal-title":"Chem Eng Sci"},{"key":"110_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2015.12.009","volume":"100","author":"SJ Dengale","year":"2016","unstructured":"Dengale SJ, Grohganz H, Rades T, L\u00f6bmann K (2016) Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev 100:116\u2013125. https:\/\/doi.org\/10.1016\/j.addr.2015.12.009","journal-title":"Adv Drug Deliv Rev"},{"key":"110_CR24","doi-asserted-by":"publisher","first-page":"31183","DOI":"10.1038\/s41598-024-82524-2","volume":"14","author":"Z Dong","year":"2024","unstructured":"Dong Z, Jin W, Wang J, Yin H, Ma Y, Hu X, Wang J, Liu C, Wang W (2024a) A drug-drug co-amorphous system for highly improved solubility of breviscapine: an experimental and computational study. Sci Rep 14:31183. https:\/\/doi.org\/10.1038\/s41598-024-82524-2","journal-title":"Sci Rep"},{"key":"110_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-82524-2","volume":"14","author":"Z Dong","year":"2024","unstructured":"Dong Z, Jin W, Wang J, Yin H, Ma Y, Hu X, Wang J, Liu C, Wang W (2024b) A drug-drug co-amorphous system for highly improved solubility of breviscapine: an experimental and computational study. Sci Rep 14:1\u201313. https:\/\/doi.org\/10.1038\/s41598-024-82524-2","journal-title":"Sci Rep"},{"key":"110_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/pharmaceutics11090425","volume":"11","author":"K Edueng","year":"2019","unstructured":"Edueng K, Bergstr\u00f6m CAS, Gr\u00e5sj\u00f6 J, Mahlin D (2019) Long-term physical (In)Stability of spray-dried amorphous drugs: relationship with glass-forming ability and physicochemical properties. Pharmaceutics 11:425. https:\/\/doi.org\/10.3390\/pharmaceutics11090425","journal-title":"Pharmaceutics"},{"key":"110_CR27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1021\/acs.molpharmaceut.4c01067","volume":"22","author":"M Elkhashab","year":"2025","unstructured":"Elkhashab M, Sartawi Z, Faisal W, Crean A (2025) Glassy drug microneedle array design: drug glass-forming ability and stability. Mol Pharm 22:1373\u20131383. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c01067","journal-title":"Mol Pharm"},{"key":"110_CR28","doi-asserted-by":"publisher","first-page":"120448","DOI":"10.1016\/j.ijpharm.2021.120448","volume":"600","author":"H Fael","year":"2021","unstructured":"Fael H, Demirel AL (2021) Indomethacin co-amorphous drug-drug systems with improved solubility, supersaturation, dissolution rate and physical stability. Int J Pharm 600:120448. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120448","journal-title":"Int J Pharm"},{"key":"110_CR29","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/cpt.1672","volume":"107","author":"C Fink","year":"2020","unstructured":"Fink C, Sun D, Wagner K, Schneider M, Bauer H, Dolgos H, M\u00e4der K, Peters S (2020) Evaluating the role of solubility in oral absorption of poorly water-soluble drugs using physiologically-based pharmacokinetic modeling. Clin Pharmacol Ther 107:650\u2013661. https:\/\/doi.org\/10.1002\/cpt.1672","journal-title":"Clin Pharmacol Ther"},{"key":"110_CR30","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3390\/molecules24122333","volume":"24","author":"P Garcia Ferreira","year":"2019","unstructured":"Garcia Ferreira P, Guimar\u00e3es de Souza Lima C, Noronha LL, de Moraes MC, Silva FdeCda, Lifsitch Vi\u00e7osa A, Omena Futuro D, Francisco Ferreira V (2019) Development of a method for the quantification of clotrimazole and itraconazole and study of their stability in a new microemulsion for the treatment of sporotrichosis. Molecules 24:2333. https:\/\/doi.org\/10.3390\/molecules24122333","journal-title":"Molecules"},{"key":"110_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.devcel.2020.09.003","volume":"55","author":"SK Goetz","year":"2020","unstructured":"Goetz SK, Mahamid J (2020) Visualizing molecular architectures of cellular condensates: hints of complex coacervation scenarios. Dev Cell 55:97\u2013107. https:\/\/doi.org\/10.1016\/j.devcel.2020.09.003","journal-title":"Dev Cell"},{"key":"110_CR32","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/jps.24541","volume":"104","author":"Y He","year":"2015","unstructured":"He Y, Ho C (2015) Amorphous solid dispersions: utilization and challenges in drug discovery and development. J Pharm Sci 104:3237\u20133258. https:\/\/doi.org\/10.1002\/jps.24541","journal-title":"J Pharm Sci"},{"key":"110_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jconrel.2022.09.056","volume":"352","author":"TN Hiew","year":"2022","unstructured":"Hiew TN, Taylor LS (2022) Combining drug salt formation with amorphous solid dispersions \u2013 a double edged sword. J Control Release 352:47\u201360. https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.056","journal-title":"J Control Release"},{"key":"110_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.xphs.2024.09.020","volume":"114","author":"TN Hiew","year":"2025","unstructured":"Hiew TN, Solomos MA, Kafle P, Polyzois H, Zemlyanov DY, Punia A, Smith D, Schenck L, Taylor LS (2025) The importance of surface composition and wettability on the dissolution performance of high drug loading amorphous dispersion formulations. J Pharm Sci 114:289\u2013303","journal-title":"J Pharm Sci"},{"key":"110_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ijpharm.2019.04.064","volume":"565","author":"D Huang","year":"2019","unstructured":"Huang D, Xie Z, Rao Q, Liamas E, Pan P, Guan S, Zhang ZJ, Lu M, Li Q (2019) Hot melt extrusion of heat-sensitive and high melting point drug: inhibit the recrystallization of the prepared amorphous drug during extrusion to improve the bioavailability. Int J Pharm 565:316\u2013324. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.064","journal-title":"Int J Pharm"},{"key":"110_CR36","doi-asserted-by":"publisher","first-page":"143694","DOI":"10.1016\/j.molstruc.2025.143694","volume":"1349","author":"NBE Ibrahim","year":"2026","unstructured":"Ibrahim NBE, Mohd-Noor F, Aziz SM (2026) Intermolecular interactions in melt-quenched co-amorphous acetaminophen-ascorbic acid-PVP K30: FTIR, XRD, and DFT analysis. J Mol Struct 1349:143694. https:\/\/doi.org\/10.1016\/j.molstruc.2025.143694","journal-title":"J Mol Struct"},{"key":"110_CR37","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.17576\/jsm-2025-5406-14","volume":"54","author":"I Indra","year":"2025","unstructured":"Indra I, Nurani R, Trisna Wulandari W (2025) Enhanced solubility and dissolution of ketoconazole through co-amorphization with fumaric and tartaric acids via co-milling. Sains Malaysiana 54:1593\u20131604. https:\/\/doi.org\/10.17576\/jsm-2025-5406-14","journal-title":"Sains Malaysiana"},{"key":"110_CR38","doi-asserted-by":"publisher","first-page":"113526","DOI":"10.1016\/j.colsurfb.2023.113526","volume":"230","author":"N Islam","year":"2023","unstructured":"Islam N, Khan NU, Razzaq A, Menaa F, Khan ZU, Hussain A, Rehman SU, Iqbal H, Ni J (2023) Loratadine oral bioavailability enhancement via solid dispersion loaded oro-dispersible films: formulation, characterization and pharmacokinetics. Colloids Surf B Biointerfaces 230:113526. https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113526","journal-title":"Colloids Surf B Biointerfaces"},{"key":"110_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/acs.molpharmaceut.5b00652","volume":"13","author":"MJ Jackson","year":"2016","unstructured":"Jackson MJ, Kestur US, Hussain MA, Taylor LS (2016) Dissolution of Danazol amorphous solid dispersions: supersaturation and phase behavior as a function of drug loading and polymer type. Mol Pharm 13:223\u2013231. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00652","journal-title":"Mol Pharm"},{"key":"110_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/jphp.12458","volume":"68","author":"KT Jensen","year":"2016","unstructured":"Jensen KT, Blaabjerg LI, Lenz E, Bohr A, Grohganz H, Kleinebudde P, Rades T, L\u00f6bmann K (2016) Preparation and characterization of spray-dried co-amorphous drug\u2013amino acid salts. J Pharm Pharmacol 68:615\u2013624. https:\/\/doi.org\/10.1111\/jphp.12458","journal-title":"J Pharm Pharmacol"},{"key":"110_CR41","doi-asserted-by":"publisher","first-page":"124913","DOI":"10.1016\/j.ijpharm.2024.124913","volume":"667","author":"M Kamruzzaman","year":"2024","unstructured":"Kamruzzaman M, Cathcart H, McLoughlin P, O\u2019Reilly NJ (2024) Evaluation of aspartame as a co-former in the preparation of co-amorphous formulations of dipyridamole using spray drying. Int J Pharm 667:124913. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124913","journal-title":"Int J Pharm"},{"key":"110_CR42","doi-asserted-by":"publisher","first-page":"102116","DOI":"10.1016\/j.jddst.2020.102116","volume":"61","author":"DN Kapote","year":"2021","unstructured":"Kapote DN, Wagner KG (2021) Influence of shellac on the improvement of solubility and supersaturation of loratadine amorphous solid dispersion using a new grade of HPMC. J Drug Deliv Sci Technol 61:102116. https:\/\/doi.org\/10.1016\/j.jddst.2020.102116","journal-title":"J Drug Deliv Sci Technol"},{"key":"110_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/pharmaceutics10030098","volume":"10","author":"A Karagianni","year":"2018","unstructured":"Karagianni A, Kachrimanis K, Nikolakakis I (2018a) Co-amorphous solid dispersions for solubility and absorption improvement of drugs: composition, preparation, characterization and formulations for oral delivery. Pharmaceutics 10:98. https:\/\/doi.org\/10.3390\/pharmaceutics10030098","journal-title":"Pharmaceutics"},{"key":"110_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/pharmaceutics10030098","volume":"10","author":"A Karagianni","year":"2018","unstructured":"Karagianni A, Kachrimanis K, Nikolakakis I (2018b) Co-amorphous solid dispersions for solubility and absorption improvement of drugs: composition, preparation, characterization and formulations for oral delivery. Pharmaceutics 10:98. https:\/\/doi.org\/10.3390\/pharmaceutics10030098","journal-title":"Pharmaceutics"},{"key":"110_CR45","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/10837450.2022.2145309","volume":"27","author":"A Karakucuk","year":"2022","unstructured":"Karakucuk A, Canpinar H, Celebi N (2022) Ritonavir nanosuspensions prepared by microfluidization with enhanced solubility and desirable immunological properties. Pharm Dev Technol 27:1027\u20131037. https:\/\/doi.org\/10.1080\/10837450.2022.2145309","journal-title":"Pharm Dev Technol"},{"key":"110_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijpharm.2018.12.036","volume":"557","author":"G Kasten","year":"2019","unstructured":"Kasten G, L\u00f6bmann K, Grohganz H, Rades T (2019) Co-former selection for co-amorphous drug-amino acid formulations. Int J Pharm 557:366\u2013373. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.12.036","journal-title":"Int J Pharm"},{"key":"110_CR47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/pharmaceutics11050202","volume":"11","author":"K Kawakami","year":"2019","unstructured":"Kawakami K (2019) Crystallization tendency of pharmaceutical glasses: relevance to compound properties, impact of formulation process, and implications for design of amorphous solid dispersions. Pharmaceutics 11:202. https:\/\/doi.org\/10.3390\/pharmaceutics11050202","journal-title":"Pharmaceutics"},{"key":"110_CR48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijpharm.2016.12.027","volume":"517","author":"K Kawakami","year":"2017","unstructured":"Kawakami K, Ohba C (2017) Crystallization of probucol from solution and the glassy state. Int J Pharm 517:322\u2013328. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.12.027","journal-title":"Int J Pharm"},{"key":"110_CR49","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/pharmaceutics13060767","volume":"13","author":"Y Kawano","year":"2021","unstructured":"Kawano Y, Chen S, Hanawa T (2021) Solubility enhancement of ibuprofen by adsorption onto spherical porous calcium silicate. Pharmaceutics 13:767. https:\/\/doi.org\/10.3390\/pharmaceutics13060767","journal-title":"Pharmaceutics"},{"key":"110_CR50","doi-asserted-by":"publisher","first-page":"126283","DOI":"10.1016\/j.ijpharm.2025.126283","volume":"686","author":"R Khemchandani","year":"2025","unstructured":"Khemchandani R, Pardhi E, Jadhav A, Devi P, Roshitha K, Bhatt N, Godugu C, Mehra NK, Samanthula G (2025) Integrated experimental, computational and machine learning approaches for the development of Apremilast-Aceclofenac coamorphous systems. Int J Pharm 686:126283. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126283","journal-title":"Int J Pharm"},{"key":"110_CR51","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/pharmaceutics16121602","volume":"16","author":"K Khorami","year":"2024","unstructured":"Khorami K, Farahani SD, M\u00fcllertz A, Rades T (2024) Drug-phospholipid co-amorphous formulations: the role of preparation methods and phospholipid selection. Pharmaceutics 16:1602. https:\/\/doi.org\/10.3390\/pharmaceutics16121602","journal-title":"Pharmaceutics"},{"key":"110_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejpb.2022.11.011","volume":"181","author":"K Kondo","year":"2022","unstructured":"Kondo K, Rades T (2022) Solventless amorphization and pelletization using a high shear granulator. Part II; preparation of co-amorphous mixture-layered pellets using indomethacin and arginine. Eur J Pharm Biopharm 181:183\u2013194. https:\/\/doi.org\/10.1016\/j.ejpb.2022.11.011","journal-title":"Eur J Pharm Biopharm"},{"key":"110_CR53","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/pharmaceutics17091090","volume":"17","author":"MM Kshirsagar","year":"2025","unstructured":"Kshirsagar MM, Chatale BC, Dyawanapelly S, Vora LK, Amin PD (2025) Continuous processing strategies for amorphous solid dispersions of Itraconazole: impact of polymer selection and manufacturing techniques. Pharmaceutics 17:1090. https:\/\/doi.org\/10.3390\/pharmaceutics17091090","journal-title":"Pharmaceutics"},{"key":"110_CR54","doi-asserted-by":"publisher","first-page":"111608","DOI":"10.1016\/j.biopha.2021.111608","volume":"139","author":"J Kuczy\u0144ska","year":"2021","unstructured":"Kuczy\u0144ska J, Nieradko-Iwanicka B (2021) Future prospects of ketoprofen in improving the safety of the gastric mucosa. Biomed Pharmacother 139:111608. https:\/\/doi.org\/10.1016\/j.biopha.2021.111608","journal-title":"Biomed Pharmacother"},{"key":"110_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.08.123","volume":"532","author":"R Laitinen","year":"2017","unstructured":"Laitinen R, L\u00f6bmann K, Grohganz H, Priemel P, Strachan CJ, Rades T (2017) Supersaturating drug delivery systems: The potential of co-amorphous drug formulations. Int J Pharm 532:1\u201312. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.123","journal-title":"Int J Pharm"},{"key":"110_CR56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ajps.2018.12.001","volume":"14","author":"F Li","year":"2019","unstructured":"Li F, Li L, Wang S, Yang Y, Li J, Liu D, Zhang S, Wang S, Xu H (2019) Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method. Asian J Pharm Sci 14:649\u2013657. https:\/\/doi.org\/10.1016\/j.ajps.2018.12.001","journal-title":"Asian J Pharm Sci"},{"key":"110_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejpb.2021.05.030","volume":"166","author":"Y-W Li","year":"2021","unstructured":"Li Y-W, Zhang H-M, Cui B-J, Hao C-Y, Zhu H-Y, Guan J, Wang D, Jin Y, Feng B, Cai J-H, Qi X-R, Shi N-Q (2021) \u201cFelodipine-indomethacin\u201d co-amorphous supersaturating drug delivery systems: \u201cspring-parachute\u201d process, stability, in vivo bioavailability, and underlying molecular mechanisms. Eur J Pharm Biopharm 166:111\u2013125. https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.030","journal-title":"Eur J Pharm Biopharm"},{"key":"110_CR58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/pharmaceutics13030389","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Grohganz H, L\u00f6bmann K, Rades T, Hempel N-J (2021) Co-amorphous drug formulations in numbers: recent advances in co-amorphous drug formulations with focus on co-formability, molar ratio, preparation methods, physical stability, in vitro and in vivo performance, and new formulation strategies. Pharmaceutics 13:389. https:\/\/doi.org\/10.3390\/pharmaceutics13030389","journal-title":"Pharmaceutics"},{"key":"110_CR59","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1021\/acs.molpharmaceut.1c00973","volume":"19","author":"J Liu","year":"2022","unstructured":"Liu J, Hwu E, Bannow J, Grohganz H, Rades T (2022) Impact of molecular surface diffusion on the physical stability of co-amorphous systems. Mol Pharm 19:1183\u20131190. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00973","journal-title":"Mol Pharm"},{"key":"110_CR60","doi-asserted-by":"publisher","first-page":"114333","DOI":"10.1016\/j.ejpb.2024.114333","volume":"200","author":"X Liu","year":"2024","unstructured":"Liu X, Shen L, Zhou L, Wu W, Liang G, Zhao Y, Wu W (2024) Nucleotides as new co-formers in co-amorphous systems: enhanced dissolution rate, water solubility and physical stability. Eur J Pharm Biopharm 200:114333. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114333","journal-title":"Eur J Pharm Biopharm"},{"key":"110_CR61","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1021\/acs.chemrev.1c00826","volume":"122","author":"N Ma","year":"2022","unstructured":"Ma N, Horike S (2022) Metal-organic network-forming glasses. Chem Rev 122:4163\u20134203. https:\/\/doi.org\/10.1021\/acs.chemrev.1c00826","journal-title":"Chem Rev"},{"key":"110_CR62","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/pharmaceutics17070850","volume":"17","author":"AAK Mahmoud","year":"2025","unstructured":"Mahmoud AAK, Regdon G, Krist\u00f3 K (2025) Cutting-edge approaches in the co-amorphization process. Pharmaceutics 17:850. https:\/\/doi.org\/10.3390\/pharmaceutics17070850","journal-title":"Pharmaceutics"},{"key":"110_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5805398","volume":"2022","author":"A Mahmoudi","year":"2022","unstructured":"Mahmoudi A, Moallem SA, Johnston TP, Sahebkar A (2022) Liver protective effect of fenofibrate in NASH\/NAFLD animal models. PPAR Res 2022:1\u201312. https:\/\/doi.org\/10.1155\/2022\/5805398","journal-title":"PPAR Res"},{"key":"110_CR64","doi-asserted-by":"publisher","unstructured":"Maria Pacifici G (2025) Clinical pharmacology of felodipine. Int J Clin Stud Med Case Rep 50. https:\/\/doi.org\/10.46998\/IJCMCR.2025.50.001245","DOI":"10.46998\/IJCMCR.2025.50.001245"},{"key":"110_CR65","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3390\/pharmaceutics14102003","volume":"14","author":"LM Mart\u00ednez","year":"2022","unstructured":"Mart\u00ednez LM, Cruz-Angeles J, V\u00e1zquez-D\u00e1vila M, Mart\u00ednez E, Cabada P, Navarrete-Bernal C, Cortez F (2022) Mechanical activation by ball milling as a strategy to prepare highly soluble pharmaceutical formulations in the form of co-amorphous, co-crystals, or polymorphs. Pharmaceutics 14:2003. https:\/\/doi.org\/10.3390\/pharmaceutics14102003","journal-title":"Pharmaceutics"},{"key":"110_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1248\/cpb.c18-00614","volume":"67","author":"K Matsuura","year":"2019","unstructured":"Matsuura K, Kojima H, Haraguchi T, Yoshida M, Suzuki S, Suzuki T, Ando S, Uchida T (2019) Preparation and characterization of itraconazole- or miconazole-loaded PLGA microspheres. Chem Pharm Bull (Tokyo) 67:106\u2013111. https:\/\/doi.org\/10.1248\/cpb.c18-00614","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"110_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/pharmaceutics10020047","volume":"10","author":"J Mishra","year":"2018","unstructured":"Mishra J, Rades T, L\u00f6bmann K, Grohganz H (2018) Influence of solvent composition on the performance of spray-dried co-amorphous formulations. Pharmaceutics 10:47. https:\/\/doi.org\/10.3390\/pharmaceutics10020047","journal-title":"Pharmaceutics"},{"key":"110_CR68","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/ijms20071718","volume":"20","author":"JB Morris","year":"2019","unstructured":"Morris JB, Tisi DA, Tan DCT, Worthington JH (2019) Development and palatability assessment of Norvir\u00ae (Ritonavir) 100 mg powder for pediatric population. Int J Mol Sci 20:1718. https:\/\/doi.org\/10.3390\/ijms20071718","journal-title":"Int J Mol Sci"},{"key":"110_CR69","doi-asserted-by":"publisher","unstructured":"Narayan R, Pednekar A, Bhuyan D, Gowda C, K K, Nayak UY (2017) A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies. Int J Nanomedicine 12:4921\u20134935. https:\/\/doi.org\/10.2147\/IJN.S141504","DOI":"10.2147\/IJN.S141504"},{"key":"110_CR70","doi-asserted-by":"publisher","first-page":"114513","DOI":"10.1016\/j.ejpb.2024.114513","volume":"204","author":"I Nyamba","year":"2024","unstructured":"Nyamba I, Sombi\u00e9 CB, Yabr\u00e9 M, Zim\u00e9-Diawara H, Yam\u00e9ogo J, Ou\u00e9draogo S, Lechanteur A, Semd\u00e9 R, Evrard B (2024) Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs. Eur J Pharm Biopharm 204:114513. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114513","journal-title":"Eur J Pharm Biopharm"},{"key":"110_CR71","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/pharmaceutics12100969","volume":"12","author":"A Ouranidis","year":"2020","unstructured":"Ouranidis A, Gkampelis N, Vardaka E, Karagianni A, Tsiptsios D, Nikolakakis I, Kachrimanis K (2020) Overcoming the solubility barrier of ibuprofen by the rational process design of a nanocrystal formulation. Pharmaceutics 12:969. https:\/\/doi.org\/10.3390\/pharmaceutics12100969","journal-title":"Pharmaceutics"},{"key":"110_CR72","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c23-00673","author":"S Oyama","year":"2024","unstructured":"Oyama S, Ogawa N, Kawai K, Iwai K, Yasunaga T, Yamamoto H (2024) Improved dissolution properties of co-amorphous probucol with atorvastatin calcium trihydrate prepared by spray-drying. Chem Pharm Bull (Tokyo). https:\/\/doi.org\/10.1248\/cpb.c23-00673","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"110_CR73","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1039\/D2CE00231K","volume":"24","author":"AB Pagliari","year":"2022","unstructured":"Pagliari AB, Meyer AR, Solner VB, Rosa JML, H\u00f6rner M, Bonacorso HG, Zanatta N, Martins MAP (2022) Effect of hydrogen bonds and \u03c0\u22ef\u03c0 interactions on the crystallization of phenyl-perfluorophenyl amides: understanding the self-organization of a cocrystal. CrystEngComm 24:5348\u20135363. https:\/\/doi.org\/10.1039\/D2CE00231K","journal-title":"CrystEngComm"},{"key":"110_CR74","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/pharmaceutics11100529","volume":"11","author":"P Panini","year":"2019","unstructured":"Panini P, Rampazzo M, Singh A, Vanhoutte F, Van den Mooter G (2019a) Myth or truth: the glass forming ability class iii drugs will always form single-phase homogenous amorphous solid dispersion formulations. Pharmaceutics 11:529. https:\/\/doi.org\/10.3390\/pharmaceutics11100529","journal-title":"Pharmaceutics"},{"key":"110_CR75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/pharmaceutics11100529","volume":"11","author":"P Panini","year":"2019","unstructured":"Panini P, Rampazzo M, Singh A, Vanhoutte F, Van den Mooter G (2019b) Myth or truth: the glass forming ability class III drugs will always form single-phase homogenous amorphous solid dispersion formulations. Pharmaceutics 11:529. https:\/\/doi.org\/10.3390\/pharmaceutics11100529","journal-title":"Pharmaceutics"},{"key":"110_CR76","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/pharmaceutics16121617","volume":"16","author":"S-J Park","year":"2024","unstructured":"Park S-J, Kim GL, Han H-K (2024) Sustained-release solid dispersions of fenofibrate for simultaneous enhancement of the extent and duration of drug exposure. Pharmaceutics 16:1617. https:\/\/doi.org\/10.3390\/pharmaceutics16121617","journal-title":"Pharmaceutics"},{"key":"110_CR77","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.3390\/polym17182484","volume":"17","author":"I Pantazos","year":"2025","unstructured":"Pantazos I, Poimenidou M, Kouskouridas D, Tzaferas E, Karava V, Cholevas C, Kapourani A, Barmpalexis P (2025) Influence of drug properties, formulation composition, and processing parameters on the stability and dissolution performance of amorphous solid dispersions-based tablets. Polymers (Basel) 17:2484. https:\/\/doi.org\/10.3390\/polym17182484","journal-title":"Polymers (Basel)"},{"key":"110_CR78","doi-asserted-by":"publisher","first-page":"121033","DOI":"10.1016\/j.ijpharm.2021.121033","volume":"608","author":"N Pe\u0161i\u0107","year":"2021","unstructured":"Pe\u0161i\u0107 N, Dap\u010devi\u0107 A, Ivkovi\u0107 B, Kachrimanis K, Mitri\u0107 M, Ibri\u0107 S, Medarevi\u0107 D (2021) Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol. Int J Pharm 608:121033. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121033","journal-title":"Int J Pharm"},{"key":"110_CR79","doi-asserted-by":"publisher","first-page":"124820","DOI":"10.1016\/j.ijpharm.2024.124820","volume":"666","author":"V Petkov","year":"2024","unstructured":"Petkov V, Vinarov Z, Tcholakova S (2024) Mechanisms of dissolution and crystallization of amorphous glibenclamide. Int J Pharm 666:124820. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124820","journal-title":"Int J Pharm"},{"key":"110_CR80","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/jmr.2432","volume":"28","author":"B Pradines","year":"2015","unstructured":"Pradines B, Gallard J, Iorga BI, Gueutin C, Ponchel G, Loiseau PM, Bouchemal K (2015) The unexpected increase of clotrimazole apparent solubility using randomly methylated \u03b2\u2010cyclodextrin. J Mol Recognit 28:96\u2013102. https:\/\/doi.org\/10.1002\/jmr.2432","journal-title":"J Mol Recognit"},{"key":"110_CR81","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2023.2195001","author":"PA Regidor","year":"2023","unstructured":"Regidor PA, Thamkhantho M, Chayachinda C, Palacios S (2023) Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature. J Obstet Gynaecol (Lahore). https:\/\/doi.org\/10.1080\/01443615.2023.2195001","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"110_CR82","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s11095-016-1870-z","volume":"33","author":"MK Riekes","year":"2016","unstructured":"Riekes MK, Engelen A, Appeltans B, Rombaut P, Stulzer HK, Van den Mooter G (2016) New perspectives for fixed dose combinations of poorly water-soluble compounds: a case study with ezetimibe and lovastatin. Pharm Res 33:1259\u20131275. https:\/\/doi.org\/10.1007\/s11095-016-1870-z","journal-title":"Pharm Res"},{"key":"110_CR83","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40262-025-01473-9","volume":"64","author":"K Rodriguez-Fernandez","year":"2025","unstructured":"Rodriguez-Fernandez K, G\u00f3mez-Mantilla JD, Shukla S, Stopfer P, Sieger P, Mangas-Sanju\u00e1n V, Peters SA (2025) Evaluation of solubility-limited absorption as a surrogate to predicting positive food effect of BCS II\/IV drugs. Clin Pharmacokinet 64:373\u2013385. https:\/\/doi.org\/10.1007\/s40262-025-01473-9","journal-title":"Clin Pharmacokinet"},{"key":"110_CR84","doi-asserted-by":"publisher","unstructured":"Roshan Gyawali, S. Rajarajan, Yuvraj Regmi, Sachin Aryal (2024) Preparation of co-amorphous system formulation of poorly aqueous soluble api\u2019s for suitable acidic & basic drug for oral drug delivery. Dinkum J Med Innov 3:442. https:\/\/doi.org\/10.71017\/djmi.3.06.d-0289","DOI":"10.71017\/djmi.3.06.d-0289"},{"key":"110_CR85","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.xphs.2020.04.008","volume":"109","author":"M Ruponen","year":"2020","unstructured":"Ruponen M, Rusanen H, Laitinen R (2020) Dissolution and permeability properties of co-amorphous formulations of hydrochlorothiazide. J Pharm Sci 109:2252\u20132261. https:\/\/doi.org\/10.1016\/j.xphs.2020.04.008","journal-title":"J Pharm Sci"},{"key":"110_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104746","volume":"86","author":"A Saberi","year":"2023","unstructured":"Saberi A, Kouhjani M, Yari D, Jahani A, Asare-Addo K, Kamali H, Nokhodchi A (2023) Development, recent advances, and updates in binary, ternary co-amorphous systems, and ternary solid dispersions. J Drug Deliv Sci Technol 86:104746. https:\/\/doi.org\/10.1016\/j.jddst.2023.104746","journal-title":"J Drug Deliv Sci Technol"},{"key":"110_CR87","doi-asserted-by":"publisher","first-page":"103863","DOI":"10.1016\/j.drudis.2023.103863","volume":"29","author":"R Shelke","year":"2024","unstructured":"Shelke R, Velagacherla V, Nayak UY (2024) Recent advances in dual-drug co-amorphous systems. Drug Discov Today 29:103863. https:\/\/doi.org\/10.1016\/j.drudis.2023.103863","journal-title":"Drug Discov Today"},{"key":"110_CR88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.apsb.2018.08.002","volume":"9","author":"Q Shi","year":"2019","unstructured":"Shi Q, Moinuddin SM, Cai T (2019) Advances in coamorphous drug delivery systems. Acta Pharm Sin B 9:19\u201335. https:\/\/doi.org\/10.1016\/j.apsb.2018.08.002","journal-title":"Acta Pharm Sin B"},{"key":"110_CR89","doi-asserted-by":"publisher","first-page":"119925","DOI":"10.1016\/j.ijpharm.2020.119925","volume":"590","author":"Q Shi","year":"2020","unstructured":"Shi Q, Li F, Yeh S, Wang Y, Xin J (2020) Physical stability of amorphous pharmaceutical solids: nucleation, crystal growth, phase separation and effects of the polymers. Int J Pharm 590:119925. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119925","journal-title":"Int J Pharm"},{"key":"110_CR90","doi-asserted-by":"publisher","unstructured":"Shinde A, Jadhav N, Shinde O, Patil P (2019) Enhancement solubility and dissolution rate of paracetamol and ibuprofen by coamorphous particles using microwave technique. Asian J Pharmaceut Clin Res 155\u2013162. https:\/\/doi.org\/10.22159\/ajpcr.2019.v12i11.34589","DOI":"10.22159\/ajpcr.2019.v12i11.34589"},{"key":"110_CR91","doi-asserted-by":"publisher","first-page":"124857","DOI":"10.1016\/j.ijpharm.2024.124857","volume":"667","author":"Y Song","year":"2024","unstructured":"Song Y, Chen Y, Heng W, Hu E, Shi Y, Gao Y, Zhang J, Wei Y, Qian S (2024) The potential of supramolecular synthon to develop coamorphous systems with tailored physical stability: mechanistic insights integrating kinetics and thermodynamics. Int J Pharm 667:124857. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124857","journal-title":"Int J Pharm"},{"key":"110_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-024-03808-w","volume":"42","author":"B Srividya","year":"2025","unstructured":"Srividya B, Ghosh A (2025) Mechanistic insights into amorphous solid dispersions: bridging theory and practice in drug delivery. Pharm Res 42:1\u201323. https:\/\/doi.org\/10.1007\/s11095-024-03808-w","journal-title":"Pharm Res"},{"key":"110_CR93","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.3390\/pharmaceutics14112398","volume":"14","author":"H Triboandas","year":"2022","unstructured":"Triboandas H, Pitt K, Bezerra M, Ach-Hubert D, Schlindwein W (2022) Itraconazole amorphous solid dispersion tablets: formulation and compaction process optimization using quality by design principles and tools. Pharmaceutics 14:2398. https:\/\/doi.org\/10.3390\/pharmaceutics14112398","journal-title":"Pharmaceutics"},{"key":"110_CR94","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/molecules30030681","volume":"30","author":"MT Viciosa","year":"2025","unstructured":"Viciosa MT, Moura Ramos JJ, Garcia AR, Diogo HP (2025) Dynamic behavior of the glassy and supercooled liquid states of aceclofenac assessed by dielectric and calorimetric techniques. Molecules 30:681. https:\/\/doi.org\/10.3390\/molecules30030681","journal-title":"Molecules"},{"key":"110_CR95","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2176692","author":"N Vunnam","year":"2023","unstructured":"Vunnam N, Young MC, Liao EE, Lo CH, Huber E, Been M, Thomas DD, Sachs JN (2023) Nimesulide, a COX-2 inhibitor, sensitizes pancreatic cancer cells to TRAIL-induced apoptosis by promoting DR5 clustering \u2020. Cancer Biol Ther. https:\/\/doi.org\/10.1080\/15384047.2023.2176692","journal-title":"Cancer Biol Ther"},{"key":"110_CR96","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1208\/s12249-017-0734-0","volume":"18","author":"J Wang","year":"2017","unstructured":"Wang J, Chang R, Zhao Y, Zhang J, Zhang T, Fu Q, Chang C, Zeng A (2017) Coamorphous loratadine-citric acid system with enhanced physical stability and bioavailability. AAPS PharmSciTech 18:2541\u20132550. https:\/\/doi.org\/10.1208\/s12249-017-0734-0","journal-title":"AAPS PharmSciTech"},{"key":"110_CR97","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/pharmaceutics15010172","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Rades T, Grohganz H (2023) Considerations on the kinetic processes in the preparation of ternary co-amorphous systems by milling. Pharmaceutics 15:172. https:\/\/doi.org\/10.3390\/pharmaceutics15010172","journal-title":"Pharmaceutics"},{"key":"110_CR98","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/molecules26061513","volume":"26","author":"W Wei","year":"2021","unstructured":"Wei W, Evseenko VI, Khvostov MV, Borisov SA, Tolstikova TG, Polyakov NE, Dushkin AV, Xu W, Min L, Su W (2021) Solubility, permeability, anti-inflammatory action and in vivo pharmacokinetic properties of several mechanochemically obtained pharmaceutical solid dispersions of nimesulide. Molecules 26:1513. https:\/\/doi.org\/10.3390\/molecules26061513","journal-title":"Molecules"},{"key":"110_CR99","unstructured":"Wishart DS (2025) DrugBank: Felodipine. In: DrugBank Online. https:\/\/go.drugbank.com\/drugs\/DB01023. Accessed 12 Dec 2025"},{"key":"110_CR100","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/pharmaceutics12121209","volume":"12","author":"SN Wong","year":"2020","unstructured":"Wong SN, Chan SWS, Peng X, Xuan B, Lee HW, Tong HHY, Chow SF (2020) Effects of the glass-forming ability and annealing conditions on cocrystallization behaviors via rapid solvent removal: a case study of voriconazole. Pharmaceutics 12:1209. https:\/\/doi.org\/10.3390\/pharmaceutics12121209","journal-title":"Pharmaceutics"},{"key":"110_CR101","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1016\/j.apsb.2024.08.027","volume":"14","author":"B Xie","year":"2024","unstructured":"Xie B, Liu Y, Li X, Yang P, He W (2024) Solubilization techniques used for poorly water-soluble drugs. Acta Pharm Sin B 14:4683\u20134716. https:\/\/doi.org\/10.1016\/j.apsb.2024.08.027","journal-title":"Acta Pharm Sin B"},{"key":"110_CR102","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1248\/cpb.c16-00604","volume":"64","author":"K Yamamoto","year":"2016","unstructured":"Yamamoto K, Kojima T, Karashima M, Ikeda Y (2016) Physicochemical evaluation and developability assessment of co-amorphouses of low soluble drugs and comparison to the co-crystals. Chem Pharm Bull (Tokyo) 64:1739\u20131746. https:\/\/doi.org\/10.1248\/cpb.c16-00604","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"110_CR103","doi-asserted-by":"publisher","first-page":"124673","DOI":"10.1016\/j.ijpharm.2024.124673","volume":"665","author":"Y Yang","year":"2024","unstructured":"Yang Y, Ke Y, Xie W, Li Z, Tao L, Shen W, Chen Y, Cheng H, Chen J, Yan G, Li W, Li M, Li J (2024) Amphiphilic disodium glycyrrhizin as a co-former for ketoconazole co-amorphous systems: biopharmaceutical properties and underlying molecular mechanisms. Int J Pharm 665:124673. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124673","journal-title":"Int J Pharm"},{"key":"110_CR104","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1039\/C8RA09710K","volume":"9","author":"M Zhang","year":"2019","unstructured":"Zhang M, Xiong X, Suo Z, Hou Q, Gan N, Tang P, Ding X, Li H (2019) Co-amorphous palbociclib\u2013organic acid systems with increased dissolution rate, enhanced physical stability and equivalent biosafety. RSC Adv 9:3946\u20133955. https:\/\/doi.org\/10.1039\/C8RA09710K","journal-title":"RSC Adv"},{"key":"110_CR105","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/pharmaceutics16121488","volume":"16","author":"Y-F Zhang","year":"2024","unstructured":"Zhang Y-F, Yao Q, Lin X-Y, Ma Y-H, Zhang H-F, Yu H, Mu S-Q, Zhang C, Geng H, Hao C-Y, Zuo L-L, Wu D, Li Y, Jin L-L, Shi N-Q (2024) Co-amorphization, dissolution, and stability of quench-cooled drug-drug coamorphous supersaturating delivery systems with RT-Unstable amorphous components. Pharmaceutics 16:1488. https:\/\/doi.org\/10.3390\/pharmaceutics16121488","journal-title":"Pharmaceutics"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-026-00110-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:17:37Z","timestamp":1788862657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-026-00110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1007\/s44446-026-00110-1","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"value":"1319-0164","type":"print"},{"value":"2213-7475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interest to disclose.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this literature review as it is based solely on previously published studies.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"47"}}